Quadrature Capital’s CRH Medical Corporation CRHM Stock Holding History

Quadrature Capital’s Portfolio CRHM Stock Details CRHM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-23,600	Closed	-$51K	–	1150
2020 Q3	$51K	Buy	+23,600	New	+$55K	﹤0.01%	700
2020 Q1	–	Sell	-62,800	Closed	-$216K	–	778
2019 Q4	$216K	Buy	+62,800	New	+$198K	0.01%	440
2018 Q4	–	Sell	-243,400	Closed	-$960K	–	768
2018 Q3	$960K	Buy	243,400 +218,000	+858%	+$803K	0.08%	256
2018 Q2	$79K	Buy	+25,400	New	+$81K	0.01%	485
2017 Q4	–	Sell	-23,900	Closed	-$62K	–	714
2017 Q3	$62K	Sell	23,900 -30,500	-56%	-$93.7K	0.01%	419
2017 Q2	$309K	Sell	54,400 -63,800	-54%	-$414K	0.02%	437
2017 Q1	$964K	Buy	+118,200	New	+$817K	0.07%	298

Other funds holding CRHM

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BGC

Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return

PRCP

Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Quadrature Capital's CRHM Position: Q4 2020 in Review

Quadrature Capital sold out of CRH Medical Corporation (CRHM) in Q4 2020, closing a stake of 23,600 shares — an estimated $51K sold.

Quadrature Capital first reported a position in CRHM in Q1 2017 and held it in 7 quarters. The position peaked at $964K in Q1 2017. 37 funds tracked by Wall St. Rank hold CRHM as of Q4 2020.

Quadrature Capital reported no remaining CRH Medical Corporation position as of Q4 2020 after selling out during the quarter.
Quadrature Capital sold 23,600 CRH Medical Corporation shares in Q4 2020, an estimated $51K.
Quadrature Capital first reported a position in CRH Medical Corporation in Q1 2017 and held it in 7 quarters.
Quadrature Capital's CRH Medical Corporation position peaked at $964K in Q1 2017.
37 funds tracked by Wall St. Rank held CRH Medical Corporation as of Q4 2020.

Based on Quadrature Capital's 13F filing for Q4 2020, filed 16 Feb 2021.